欧洲精密诊断市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型(基因测试、深奥测试等)、应用(肿瘤学、心脏病学、呼吸系统疾病、免疫学等)和结束用户(临床实验室、医院、家庭护理等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 149    |    Report Code: BMIRE00026144    |    Category: Life Sciences

Europe Precision Diagnostics Market

欧洲精准诊断市场预计将从2022年的23,317.64 百万美元增长到48,500.85美元到 2028 年将超过 100 万。预计 2022 年至 2028 年复合年增长率将达到 13.0%。

 

医疗保健是进入个性化方法时代,根据精确的疾病模式进行量身定制的治疗。晚期疾病诊断的生存率较低,治疗发病率较高,医疗费用较高。诊断作为个性化医疗的第一步,旨在根据患者的具体信息来表征疾病,尽早发现和预防疾病。例如,非小细胞肺癌 (NSCLC) 最早诊断的患者的 5 年生存率预计将提高到 90% 以上,而转移阶段的患者只有 10%。< /p>

 

精准诊断有助于准确、及时地解释患者的健康问题,以便及时提供治疗。由于基因组学研究和生物标志物的进步,个性化医疗的效率和目标特异性以及更好的患者治疗效果,对个性化医疗的需求更大。对个性化医疗和治疗程序的需求不断增长,对诊断产品的需求也随之激增,因为它可以让医疗专业人员准确诊断患者并解决健康问题。

 

了解疾病分子基础的患者可以获得个性化治疗。它越来越受欢迎,基因测试和基因组测序是了解疾病分子基础的重要工具。新诊断工具的进步正在进一步推进,精度更高。此外,欧洲国家还对许多遗传性疾病进行筛查,因为及早发现这些疾病可以防止症状的出现或减轻疾病的严重程度。例如,COVID-19 大流行病例的突然增加加速了对有效诊断程序和产品的需求。

 

诊断测试是支柱应对 COVID-19 的行动,支持减少病例的遏制工作,并加速采用诊断解决方案,为患者提供早期治疗。因此,通过精准诊断测试来早期诊断疾病的需求不断增长,正在推动市场的发展。

 

欧洲精准诊断市场到 2028 年的收入和预测(百万美元)

< strong> 

欧洲精准诊断市场细分      

 

欧洲精准诊断市场< /span> 按类型、应用程序、最终用户和国家/地区进行细分。根据类型,市场分为基因测试、深奥测试等。 2022 年,基因测试领域在市场中占据主导地位。

 

根据应用,市场细分为肿瘤学、心脏病学、免疫学、呼吸系统疾病等。 2022 年,肿瘤学领域在市场中占据主导地位。根据最终用户,市场分为医院、临床实验室、家庭护理等。 2022 年,临床实验室领域在市场中占据主导地位。

 

根据国家/地区,市场< /span>分为德国、法国、英国、意大利、西班牙和欧洲其他地区。此外,德国将在 2022 年占据市场主导地位。

 

主导欧洲精准诊断市场的几个主要参与者是雅培;拜耳公司;皇家飞利浦公司; Lantheus 医学影像公司;诺华公司;凯杰;奎斯特诊断公司;赛诺菲;西门子医疗股份公司;和瑞士精密诊断有限公司。



Europe Precision Diagnostics Strategic Insights

Strategic insights for Europe Precision Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-precision-diagnostics-market-strategic-framework.webp
Get more information on this report

Europe Precision Diagnostics Report Scope

Report Attribute Details
Market size in 2022 US$ 23,317.64 Million
Market Size by 2028 US$ 48,500.85 Million
Global CAGR (2022 - 2028) 13.0%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 基因测试
  • 深奥测试
By 应用
  • 肿瘤科
  • 心脏病科
  • 呼吸系统疾病科
  • 免疫科
By 最终用户
  • 临床实验室
  • 医院
  • 家庭护理
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Abbott
  • Bayer AG
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Novartis AG
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Sanofi
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH
  • Get more information on this report

    Europe Precision Diagnostics Regional Insights

    The regional scope of Europe Precision Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-precision-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Precision Diagnostics Market

    1. Abbott
    2. Bayer AG
    3. Koninklijke Philips N.V.
    4. Lantheus Medical Imaging, Inc.
    5. Novartis AG
    6. QIAGEN
    7. Quest Diagnostics Incorporated
    8. Sanofi
    9. Siemens Healthineers AG
    10. Swiss Precision Diagnostics GmbH
    Frequently Asked Questions
    How big is the Europe Precision Diagnostics Market?

    The Europe Precision Diagnostics Market is valued at US$ 23,317.64 Million in 2022, it is projected to reach US$ 48,500.85 Million by 2028.

    What is the CAGR for Europe Precision Diagnostics Market by (2022 - 2028)?

    As per our report Europe Precision Diagnostics Market, the market size is valued at US$ 23,317.64 Million in 2022, projecting it to reach US$ 48,500.85 Million by 2028. This translates to a CAGR of approximately 13.0% during the forecast period.

    What segments are covered in this report?

    The Europe Precision Diagnostics Market report typically cover these key segments-

  • 类型 (基因测试, 深奥测试)
  • 应用 (肿瘤科, 心脏病科, 呼吸系统疾病科, 免疫科)
  • 最终用户 (临床实验室, 医院, 家庭护理)
  • What is the historic period, base year, and forecast period taken for Europe Precision Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Precision Diagnostics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Europe Precision Diagnostics Market?

    The Europe Precision Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Bayer AG
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Novartis AG
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Sanofi
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH
  • Who should buy this report?

    The Europe Precision Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Precision Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.